Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SeaWorld Entertainment (SEAS) Tops Q1 EPS by 8c
- Orbital ATK (OA) Misses Q1 EPS by 17c; Reaffirms Outlook
- Cott Corp. (COT) Reports In-Line Q1 EPS
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!